Constriction, Pathologic: Clinical Trials

3 trials for Constriction, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3

Follow Constriction, Pathologic: new trials by email Literature Review of Constriction, Pathologic trials Research Report on Constriction, Pathologic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation
Colchicine, Placebo - Atrial Fibrillation, Post-pericardiotomy Syndrome
Phase 3TerminatedMayo Clinic22015-05-012017-06-21
Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
Abciximab - Stroke, Stenosis
Phase 3TerminatedUniversity of Zurich1002004-04-012007-05-03
Aspirin Or Warfarin To Prevent Stroke
Warfarin, Aspirin - Stroke, Cerebral Infarction
Phase 3TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)2006-06-06

Narrower conditions

Stroke (2)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Carotid Stenosis (1)  ·  Cerebral Infarction (1)  ·  Ischemic Attack, Transient (1)  ·  Ischemic Stroke (1)  ·  Postpericardiotomy Syndrome (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arterial Occlusive Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Vascular Diseases (2)  ·  Arrhythmias, Cardiac (1)  ·  Arteriosclerosis (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Carotid Artery Diseases (1)

Interventions

Abciximab (1)  ·  Aspirin (1)  ·  Colchicine (1)  ·  Warfarin (1)

Sponsors

Mayo Clinic (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University of Zurich (1)

Countries

United States (2)  ·  Switzerland (1)

Top investigators

Jae Oh, MD (1)  ·  Marc Chimowitz (1)  ·  Ralf W. Baumgartner, MD (1)